RU2063761C1 - Method for obtaining antiinflammatory and immunostimulating substance from placenta - Google Patents
Method for obtaining antiinflammatory and immunostimulating substance from placenta Download PDFInfo
- Publication number
- RU2063761C1 RU2063761C1 SU5013746A RU2063761C1 RU 2063761 C1 RU2063761 C1 RU 2063761C1 SU 5013746 A SU5013746 A SU 5013746A RU 2063761 C1 RU2063761 C1 RU 2063761C1
- Authority
- RU
- Russia
- Prior art keywords
- placenta
- obtaining
- antiinflammatory
- immunostimulating substance
- substance
- Prior art date
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Изобретение относится к медицине, а именно к способу получения лекарственных средств из биологических веществ. The invention relates to medicine, namely to a method for producing medicines from biological substances.
Наиболее близким к заявляемому способу является способ получения лекарственного средства "Терапевтический агент", патент США N 4054648, А 61 К 35/50, 1977г. Closest to the claimed method is a method of obtaining a medicinal product "Therapeutic agent", US patent N 4054648, A 61 K 35/50, 1977
Способ осуществляют следующим образом. The method is as follows.
Плаценту измельчают, добавляют жидкость, согласно изобретению, используют плаценту с амниотической оболочкой, надосадочную жидкость подвергают ультрафильтрации. Поставленная цель достигается также тем, что взятую амниотическую оболочку вместе с плацентой замораживают, затем размораживают. Полученный препарат хранят в морозильной камере, а перед применением размораживают и согревают до 36oС. Возможна лиофилизация препарата, лиофилизат хранят в темном прохладном месте.The placenta is crushed, the liquid according to the invention is added, the placenta with an amniotic membrane is used, the supernatant is subjected to ultrafiltration. This goal is also achieved by the fact that the taken amniotic membrane along with the placenta is frozen, then thawed. The resulting preparation is stored in a freezer, and before use it is thawed and warmed to 36 o C. Lyophilization of the preparation is possible, the lyophilisate is stored in a dark, cool place.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU5013746 RU2063761C1 (en) | 1991-11-22 | 1991-11-22 | Method for obtaining antiinflammatory and immunostimulating substance from placenta |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU5013746 RU2063761C1 (en) | 1991-11-22 | 1991-11-22 | Method for obtaining antiinflammatory and immunostimulating substance from placenta |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2063761C1 true RU2063761C1 (en) | 1996-07-20 |
Family
ID=21590133
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU5013746 RU2063761C1 (en) | 1991-11-22 | 1991-11-22 | Method for obtaining antiinflammatory and immunostimulating substance from placenta |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2063761C1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1549328A4 (en) * | 2002-09-18 | 2009-07-08 | Emiliano Ghinelli | Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin |
-
1991
- 1991-11-22 RU SU5013746 patent/RU2063761C1/en active
Non-Patent Citations (1)
Title |
---|
Патент США N 4054648, A 61 K 35/50, 1977. * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1549328A4 (en) * | 2002-09-18 | 2009-07-08 | Emiliano Ghinelli | Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin |
US7871646B2 (en) | 2002-09-18 | 2011-01-18 | Repsco Llp | Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2063761C1 (en) | Method for obtaining antiinflammatory and immunostimulating substance from placenta | |
ATE180277T1 (en) | PLANT PROTEIN USEFUL FOR THE TREATMENT OF TUMORS AND HIV INFECTIONS | |
US4048308A (en) | Acellular planktonic product, method of preparing same and cosmetic composition containing the same | |
RU2211700C2 (en) | Method for obtaining "squaakan" medicinal preparation | |
Isaksson-Forsén et al. | Partial purification of the epidermal G2 chalone based on an in vivo assay system | |
US5707657A (en) | Food supplement containing animal fetal mesenchymal matter and animal fetal organ extracts | |
JPH03504507A (en) | Protein fractions derived from the photosynthetic system of plants applied as active substances for selective dissociation of cancer cells and post-treatment of wounds, keloids and inflammation, and pharmaceutical products containing said protein fractions | |
SU975017A1 (en) | Method of producing thymozine | |
RU2059411C1 (en) | Method of preparing bioactive substances from the velvet antlers | |
US3655875A (en) | Clam extract effective against sarcoma 180 and krebs-2 carcinoma in mice | |
RU2137486C1 (en) | Human placenta allogenic preparation showing anti-inflammatory, reparative, antibacterial, wound-healing effect and method of its preparing | |
BOYER et al. | Effect of salicylate therapy on cartilage destruction in experimental pyarthrosis | |
WO1994004551A1 (en) | Method of obtaining sodium salt of native dna | |
RU2119340C1 (en) | Agent for treatment of long unhealing wounds | |
RU2136296C1 (en) | Method of preparing peptides showing antogonadotropic effect | |
RU2007181C1 (en) | Process for preparing biological material for substrate of soft and solid medicinal forms and cosmetics | |
RU2067868C1 (en) | Method of preparing basic proteinase inhibitor from cattle organs | |
RU2036648C1 (en) | Process for manufacture of peptides capable of producing antiproteasic, immunostimulating and hypotensive effects | |
RU2132199C1 (en) | Method of preparing curative-prophylactic agent from jerusalem artichoke showing biologically active effect on body | |
US20140242196A1 (en) | Method of treating venomous bites | |
RU2266127C2 (en) | Method for preparing ointment for erysipelas treatment | |
SU651812A1 (en) | Method of preventing commissure formation | |
SU1012913A1 (en) | Method of producing gonadotropic preparation "gravotadge" | |
Warrell | Isolation of IgG to Crotalus venom by affinity chromatography: Russell, FE, Sullivan, JB, and Egen, NB (Department of Health Sciences, University of Arizona, Tucson, AZ, USA) | |
Warrell | Management of envenomised snake bites with low dose antivenom: Sreeharan, N. and Ganeshamoorthy, J.(Faculty of Medicine, University of Jaffna, Sri Lanka) |